Evidence map›Paper›PMID 30429238›Full record

ArticleBioscience reports2019

Yanghe Huayan decoction inhibits the capability of trans-endothelium and angiogenesis of HER2+ breast cancer via pAkt signaling.

Xiao-Fei Liu, Jing-Wei Li, Hong-Zhi Chen, Zi-Yuan Sun, Guang-Xi Shi, Jian-Min Zhu, Ai-Li Song, Ying Wang, Xiang-Qi Li

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Host angiogenic reprogramming byFrontiers in microbiology · 2025
    Article
  6. Traditional Chinese Medicine for Breast Cancer: A Review.Breast cancer (Dove Medical Press) · 2023
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Xiao-Fei LiuFirst Clinical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Jing-Wei LiDepartment of Breast Surgery, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China weilandetian@163.com wangying8108@suda.edu.cn drlixqi@hotmail.com.
Hong-Zhi ChenCollege of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medecine, Jinan, Shandong, China.
Zi-Yuan SunDepartment of Breast Surgery, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Guang-Xi ShiDepartment of Breast Surgery, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Jian-Min ZhuDepartment of Breast Surgery, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Ai-Li SongDepartment of Breast Surgery, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Ying WangDepartment of Cardiovascular Surgery, The Affiliated Hospital of Soochow University, Suzhou, China weilandetian@163.com wangying8108@suda.edu.cn drlixqi@hotmail.com.ORCID 0000-0001-6863-8383
Xiang-Qi LiDepartment of Breast Surgery, Affiliated Hospital of Taishan Medical University, Tai'an, Shandong, China weilandetian@163.com wangying8108@suda.edu.cn drlixqi@hotmail.com.
Affiliated Hospital of Shandong University of Traditional Chinese Medicine · CNShandong University of Traditional Chinese Medicine · CNAffiliated Hospital of Taishan Medical University · CNSoochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Angiogenesis InhibitorsAnimalsAntineoplastic Combined Chemotherapy ProtocolsBreast NeoplasmsCell Line, TumorDrugs, Chinese HerbalEndothelium, VascularErb-b2 Receptor Tyrosine KinasesFemaleHumansHuman Umbilical Vein Endothelial CellsMice, NudeNeovascularization, PathologicProto-Oncogene Proteins c-aktTrastuzumabXenograft Model Antitumor AssaysAngiogenesis InhibitorsDrugs, Chinese HerbalERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesProto-Oncogene Proteins c-aktTrastuzumabangiogenesisbreast cancerpAkt signalingtrans-endotheliumYanghe Huayan Decoction

Identifiers

PMID30429238
PMCPMC6379224
OpenAlexW2900618519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.